A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk’s weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according to data shared exclusively with Reuters.
Source: ctv business
Wegovy fuels sharp rise in use of weight-loss drugs for U.S. youth

